<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04617652</url>
  </required_header>
  <id_info>
    <org_study_id>R142</org_study_id>
    <nct_id>NCT04617652</nct_id>
  </id_info>
  <brief_title>Smooth Extubation With Magnesium Sulphate for General Anesthesia With Endotracheal Intubation</brief_title>
  <official_title>Efficacy of Magnesium Sulphate on Smoothness of Extubation in Patients Undergoing General Anaesthesia With Endotracheal Intubation: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fayoum University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fayoum University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tracheal extubation is a critical event in the anaesthetic management of patients undergoing&#xD;
      general anaesthesia with endotracheal intubation for elective procedures. It the state of art&#xD;
      to provide suitable conditions for smooth extubation and avoid coughing, bucking, straining&#xD;
      and/or laryngospasm. Several methods have been described to provide a smooth extubation,&#xD;
      including the use of remifentanil infusion, dexmedetomidine or fentanyl. Because of its&#xD;
      anti-inflammatory and analgesic effects and lack of respiratory depressant actions, magnesium&#xD;
      sulphate could be an attractive alternative.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A written informed consent will be obtained from all the patients. On arrival to the&#xD;
      preparation room intravenous cannula will be inserted, no sedation will be given. In the&#xD;
      operating theater standard monitors, non-invasive blood pressure, oxygen saturation and&#xD;
      electrocardiogram will be applied before induction of anesthesia, capnography after induction&#xD;
      of anesthesia and baseline heart rate (HR), mean arterial blood pressure (MAP) and oxygen&#xD;
      saturation (SpO2 ) will be recorded.&#xD;
&#xD;
      All patients in both groups will receive standardized anesthetic technique in the form of&#xD;
      intravenous (i.v.) propofol 2 mg/kg, i.v. fentanyl 1-2 lg/kg and atracurium 0.5 mg/kg to&#xD;
      facilitate endo-tracheal intubation, mechanical ventilation will be adjusted to keep end&#xD;
      tidal carbon dioxide (EtCO2) between 30 and 35 mmHg, and all drugs will be based on ideal&#xD;
      body weight. Isoﬂurane 1% in 50% oxygen and air, and 0.15 mg/kg atracurium every 20 min will&#xD;
      be given for maintenance of anesthesia. Intraoperative HR, MAP, EtCO2 and SpO2 values will be&#xD;
      recorded at 5- minute intervals till the end of operation. HR and MAP will be maintained&#xD;
      within ±20% of the baseline values. Hypotension (deﬁned as MAP &lt; 20% of the baseline value)&#xD;
      will be treated by a bolus of 200 ml Ringer's solution if not responding increments of 3-9 mg&#xD;
      ephedrine will be given. Hypertension (deﬁned as MAP &gt; 20% of the baseline value) and/or&#xD;
      tachycardia (deﬁned as HR &gt; 20% of the baseline value) a supplemental dose (25-50 µg)&#xD;
      fentanyl will be given or increasing concentration of isoﬂurane. Bradycardia (HR &lt; 50 beat&#xD;
      per minute) persisting for &gt;2 min will be treated with atropine, 0.4 mg i.v. boluses.&#xD;
      Intra-operatively i.v. ondansetron, 4 mg (Zofran, GlaxoSmithKline) will be given for&#xD;
      prevention of postoperative nausea and vomiting. After induction of anaesthesia patients will&#xD;
      be divided into 2 groups: group C (control group) n= 30 patients will receive 10 ml of&#xD;
      saline, then infusion of 50 ml of normal saline over one hour. Group M (magnesium group n=30&#xD;
      patients) will receive 1 gm of magnesium in 10 ml over 5 minutes then infusion of 1 gm in 50&#xD;
      ml over one hour.&#xD;
&#xD;
      By the end of surgery isoﬂurane will be discontinued and the residual neuromuscular block&#xD;
      will be antagonized with neostigmine 0.05 mg/kg, given with atropine 0.02 mg/kg, the&#xD;
      endotracheal tube will be removed after return of spontaneous breathing, and the patient will&#xD;
      obey commands in semi-sitting position, then the patient will be transferred to the&#xD;
      post-anesthesia care unit (PACU)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Actual">April 1, 2021</completion_date>
  <primary_completion_date type="Actual">February 1, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>smoothness of extubation</measure>
    <time_frame>Procedure (At time of extubation)</time_frame>
    <description>Smoothness of extubation Grade&#xD;
No coughing on endotracheal tube&#xD;
Coughing on the tube&#xD;
Vomiting&#xD;
Laryngospasm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sedation score</measure>
    <time_frame>1 hrs after extubation</time_frame>
    <description>Ramsey sedation score (RSS): 1 - Anxious, agitated or restless; 2 - Cooperative and oriented; 3 - Responsive to commands; 4 - Asleep, but response to light glabellar tap or loud auditory; 5 - Asleep, sluggish response to glabellar tab or auditory response; and 6 - Asleep, no response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sedation score</measure>
    <time_frame>1 hour after extubation</time_frame>
    <description>Ramsey sedation score (RSS): 1 - Anxious, agitated or restless; 2 - Cooperative and oriented; 3 - Responsive to commands; 4 - Asleep, but response to light glabellar tap or loud auditory; 5 - Asleep, sluggish response to glabellar tab or auditory response; and 6 - Asleep, no response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>5 minutes before induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>5 minutes before induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>5 minutes before induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EtCO2</measure>
    <time_frame>5 minutes before induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>5 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>5 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>5 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EtCO2</measure>
    <time_frame>5 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>10 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>10 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>10 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EtCO2</measure>
    <time_frame>10 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>15 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>15 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>15 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EtCO2</measure>
    <time_frame>15 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>20 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial blood pressure</measure>
    <time_frame>20 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>20 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EtCO2</measure>
    <time_frame>20 minutes after induction of anathesia</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale (VAS) pain score</measure>
    <time_frame>4 hours after extubation</time_frame>
    <description>the quality of analgesia between (0-100 mm) where 0=no pain and 100 = worst comprehensible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale (VAS) pain score</measure>
    <time_frame>6 hours after extubation</time_frame>
    <description>the quality of analgesia between (0-100 mm) where 0=no pain and 100 = worst comprehensible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The duration of surgery</measure>
    <time_frame>5 minutes after extubation</time_frame>
    <description>time needed to perform surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative fentanyl needed</measure>
    <time_frame>5 minutes after extubation</time_frame>
    <description>The amount of Fentanyl given intraoperative as fentanyl will be given when either heart rate or NIBP(Non-Invasive Blood Pressure) report an increase by more than 20% of the basal records</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The cumulative opioids (morphine) consumption</measure>
    <time_frame>6 hours after surgery</time_frame>
    <description>The total amount of opioids received post operative</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Smooth Extubation</condition>
  <arm_group>
    <arm_group_label>Group M</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Magnesium group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium sulfate</intervention_name>
    <description>Patients will receive 1 gm of magnesium in 10 ml over 5 minutes then infusion of 1 gm in 50 ml over one hour.</description>
    <arm_group_label>Group M</arm_group_label>
    <other_name>Magnesium Group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Patients will receive 10 ml of saline, then infusion of 50 ml of normal saline over one hour.</description>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Placebo Group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective surgeries that need endotracheal intubation.&#xD;
&#xD;
          -  Duration of surgery 1-3 hours&#xD;
&#xD;
          -  ASA Ⅰ-Ⅱ&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal of patients.&#xD;
&#xD;
          -  Patients with hypersensitivity to the study drug.&#xD;
&#xD;
          -  Patients with cardiac disorders, bundle branch block, hart block&#xD;
&#xD;
          -  Neuromuscular disease, calcium channel blocker medication or hypermagnesemia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Atef S Khalil, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fayoum University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fayoum University hospital</name>
      <address>
        <city>Fayoum</city>
        <state>Fayoum, Madīnat Al Fayyūm, Faiyum Governorate, Egypt</state>
        <zip>63514</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 23, 2020</study_first_submitted>
  <study_first_submitted_qc>November 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2020</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fayoum University Hospital</investigator_affiliation>
    <investigator_full_name>Atef Mohamed Sayed mahmoud</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Magnesium Sulphate</keyword>
  <keyword>General Anesthesia</keyword>
  <keyword>Endotracheal Intubation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

